NCT00004832View on ClinicalTrials.gov

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 1994

Study Completion Date

June 30, 1998

Conditions
Lambert-Eaton Myasthenic Syndrome
Interventions
DRUG

3,4-diaminopyridine

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
collaborator

Duke University

OTHER

lead

FDA Office of Orphan Products Development

FED

NCT00004832 - Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome | Biotech Hunter | Biotech Hunter